.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

AstraZeneca
Colorcon
Healthtrust
Harvard Business School
Medtronic
Chubb
Cantor Fitzgerald
Citi
Daiichi Sankyo
Moodys

Generated: July 26, 2017

DrugPatentWatch Database Preview

Peramivir - Generic Drug Details

« Back to Dashboard

What are the generic sources for peramivir and what is the scope of peramivir freedom to operate?

Peramivir
is the generic ingredient in one branded drug marketed by Biocryst and is included in one NDA. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Peramivir has fifty-four patent family members in twenty-seven countries.

There is one drug master file entry for peramivir. One supplier is listed for this compound.

Summary for Generic Name: peramivir

Tradenames:1
Patents:4
Applicants:1
NDAs:1
Drug Master File Entries: see list1
Suppliers / Packagers: see list1
Bulk Api Vendors: see list59
Clinical Trials: see list14
Patent Applications: see list37
Drug Prices:see low prices
DailyMed Link:peramivir at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Biocryst
RAPIVAB
peramivir
SOLUTION;IV (INFUSION)206426-001Dec 19, 2014RXYesYes► Subscribe► SubscribeY ► Subscribe
Biocryst
RAPIVAB
peramivir
SOLUTION;IV (INFUSION)206426-001Dec 19, 2014RXYesYes► Subscribe► Subscribe ► Subscribe
Biocryst
RAPIVAB
peramivir
SOLUTION;IV (INFUSION)206426-001Dec 19, 2014RXYesYes► Subscribe► Subscribe► Subscribe
Biocryst
RAPIVAB
peramivir
SOLUTION;IV (INFUSION)206426-001Dec 19, 2014RXYesYes► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: peramivir

Country Document Number Estimated Expiration
Australia2006341592► Subscribe
Eurasian Patent Organization200870430► Subscribe
Canada2315262► Subscribe
Canada2642260► Subscribe
Austria425955► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
Harvard Business School
Teva
US Army
Boehringer Ingelheim
QuintilesIMS
Farmers Insurance
Citi
Fuji
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot